Clover Health Investments (CLOV) Projected to Post Earnings on Thursday

Clover Health Investments (NASDAQ:CLOV) is expected to be posting its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect Clover Health Investments to post earnings of ($0.05) per share and revenue of $467.0560 million for the quarter. Parties are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, February 26, 2026 at 5:00 PM ET.

Clover Health Investments Stock Performance

Shares of Clover Health Investments stock opened at $2.09 on Thursday. Clover Health Investments has a fifty-two week low of $2.01 and a fifty-two week high of $4.80. The company has a market capitalization of $1.08 billion, a P/E ratio of -19.00 and a beta of 2.09. The company has a fifty day moving average of $2.42 and a 200 day moving average of $2.65.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Zacks Research downgraded Clover Health Investments from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 24th. Wall Street Zen upgraded shares of Clover Health Investments from a “sell” rating to a “hold” rating in a research report on Sunday. Weiss Ratings restated a “sell (d-)” rating on shares of Clover Health Investments in a research report on Monday, December 29th. Finally, Canaccord Genuity Group reaffirmed a “buy” rating and set a $3.70 target price on shares of Clover Health Investments in a research note on Tuesday, January 20th. One research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $3.23.

Hedge Funds Weigh In On Clover Health Investments

Several institutional investors have recently bought and sold shares of the business. Tudor Investment Corp ET AL purchased a new position in shares of Clover Health Investments in the 4th quarter worth $458,000. Quadrature Capital Ltd bought a new position in shares of Clover Health Investments in the 4th quarter valued at about $29,000. Schonfeld Strategic Advisors LLC purchased a new position in Clover Health Investments in the fourth quarter worth about $29,000. Abel Hall LLC bought a new stake in Clover Health Investments during the fourth quarter worth approximately $27,000. Finally, California State Teachers Retirement System raised its position in Clover Health Investments by 6.3% during the fourth quarter. California State Teachers Retirement System now owns 400,548 shares of the company’s stock valued at $941,000 after purchasing an additional 23,889 shares during the period. Institutional investors own 19.77% of the company’s stock.

About Clover Health Investments

Clover Health Investments is a technology-driven healthcare company specializing in Medicare Advantage plans for senior populations. The company combines insurance coverage with a proprietary software platform to improve care coordination, outcomes tracking and cost management. By leveraging data analytics, Clover Health aims to deliver personalized care pathways and preventive interventions for its members.

At the core of Clover’s offering is its Clover Assistant platform, which aggregates clinical and claims data from multiple sources to create real-time insights for physicians and care teams.